Readouts in hepatocellular carcinoma, as well as pancreatic, gastric and salivary gland cancer, are capturing attention at ...

Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical ...

New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and ...

As weight loss medications containing active ingredients like semaglutide continue to define a new chapter in metabolic ...

Renexxion plans to file new drug application (NDA) with the Food and Drug Administration (FDA) using future Phase 3 results ...

Largest cellular study of gut tissue unveils the genes and pathways driving inflammatory bowel disease, suggesting new therapeutic targets.

The review highlights nanocarriers, microspheres, hydrogels, microneedles, long-acting formulations, and co-formulations as ...

Scientists have created the most detailed cell map to date showing how genetic variation influences inflammatory bowel disease (IBD), revealing the specific cells and genes that drive the disease.

Many use ibuprofen without a second thought, but it has hidden risks. Discover why talking to your doctor first matters. Are ...

Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology’s annual conference but its biggest data ...

The combination regimen significantly improved progression-free survival and objective response rates in patients who were intolerant to or failed prior imatinib therapy ...